Twenty-four-week oral dosing toxicities of Herba Siegesbeckiae in rats

Jia Ying Wu, Yuen Cheung Chan, Hui Guo, Ying Jie Chen, Yu Xi Liu, Hua Yi, Zhi Ling Yu*

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

7 Citations (Scopus)


Background: Herba Siegesbeckiae (HS), the dried aerial parts of Siegesbeckia orientalis L., S. pubescens Makino, or S. glabrescens Makino, is traditionally used for treating chronic diseases in China. However, there is no information about the chronic toxicity of HS. The objective of this study is to evaluate the 24-week oral dosing toxicities of HS aqueous extract (HSE) in rats.

Methods: S. orientalis-originated HS was reflux-extracted with distilled water. Sprague–Dawley rats were randomly divided into four groups, with 10 males and 10 females in each group. The rats were intragastrically administered with HSE at 5, 1.67 and 0.56 g/kg (experimental groups) or an equal volume of distilled water (control group), 6 days a week, for 24 weeks. The high dose of HSE (5 g/kg) was its maximum tolerated dose. Body weight was recorded every 2 days during the experimental period. Chemical, hematological and histopathological parameters, as well as organ weights, were measured at the end of the experiment.

Results: Decreased body weight gain; increased liver and lung relative weights; histopathological alterations in liver and lung tissues; elevated serum levels of alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase and lactate dehydrogenase were found after HSE treatments. In liver tissues, HSE treatment upregulated levels of three pro-inflammatory cytokines: IL-6, IL-1β and TNF-α. In lung tissues, HSE treatment caused oxidative stress and activated mitogen-activated protein kinases (MAPKs).

Conclusion: Long-term oral administration of HSE caused toxicities in rats evidenced by decreased body weight gain, as well as liver and lung damage. Treatment-induced oxidative stress, inflammation and MAPK activation are involved in HSE’s toxicities. Caution should be taken when using HS to treat chronic diseases.

Original languageEnglish
Article number341
JournalBMC Complementary Medicine and Therapies
Issue number1
Publication statusPublished - Dec 2020

Scopus Subject Areas

  • Complementary and alternative medicine
  • Medicine(all)

User-Defined Keywords

  • Chronic toxicity
  • Hepatotoxicity
  • Herba Siegesbeckiae
  • Pulmonary toxicity
  • Rats


Dive into the research topics of 'Twenty-four-week oral dosing toxicities of Herba Siegesbeckiae in rats'. Together they form a unique fingerprint.

Cite this